** ReNerve RNV.AX swells 98.8% to a record high of A$0.220; last up 40.9%
** Stock set for biggest ever intraday pct gain
** Medical devices maker says patients using its NervAlign® Nerve Cuff, which aids regeneration of peripheral nerves after surgery or injury, reported significantly lower post-surgery pain
** RNV set to end the quarter 11.4% lower
** About 4.5 mln shares traded in stock's busiest session ever
** RNV loses 5.7% YTD
(Reporting by Manasi Dasa Sundeep in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。